Search Within

Bone Marrow Transplant

Formats
  1. Meeting Abstract (1531)
  2. Journal Article (1198)
  3. Review (75)
  4. Research Letter (49)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (24)
  8. Correspondence (18)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (2971)
  2. Department of Medicine (2971)
  3. Hematologic Malignancies, Division of (2848)
  4. Survivorship Research (1389)
  5. GSK Faculty (931)
  6. CTCR Scholars (874)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Sean Devlin (470)
  4. Ann Jakubowski (459)
  5. Gunjan Shah (447)
  6. Heather Landau (436)

More People

Years
  1. 2025 (68)
  2. 2024 (212)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (887)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (127)
  5. Transplantation and Cellular Therapy (113)
  6. Blood Advances (95)

More Publications

Publishers
  1. American Society of Hematology (989)
  2. Elsevier Inc. (767)
  3. Nature Publishing Group (261)
  4. American Society of Clinical Oncology (130)
  5. Wiley Blackwell (66)
  6. Taylor & Francis Group (65)

More Publishers

Results (2971)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of induction therapy with VRD versus VCD on outcomes in patients with multiple myeloma in partial response or better undergoing upfront autologous stem cell transplantation
    Journal Article

    Sidana, S.; Kumar, S.; Fraser, R.; Estrada-Merly, N.; Giralt, S.; Agrawal, V.; Anderson, L. D. Jr; Aljurf, M.; Banerjee, R.; Bashey, A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation is feasible in patients with prior COVID-19 infection
    Journal Article

    Shah, N.; Dahi, P. B.; Ponce, D. M.; Sauter, C. S.; Shaffer, B. C.; Chung, D. J.; Politikos, I.; Lin, R. J.; Giralt, S. A.; Papanicolaou, G.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Immune reconstitution following high-dose chemotherapy and autologous stem cell transplantation with or without pembrolizumab maintenance therapy in patients with lymphoma
    Journal Article

    Merryman, R. W.; Redd, R.; Jeter, E.; Wong, J. L.; McHugh, K.; Reynolds, C.; Nazzaro, M.; Varden, A.; Brown, J. R.; Crombie, J. L.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Post-transplantation cyclophosphamide is associated with an increase in non-cytomegalovirus herpesvirus infections in patients with acute leukemia and myelodysplastic syndrome
    Journal Article

    Singh, A.; Dandoy, C. E.; Chen, M.; Kim, S.; Mulroney, C. M.; Kharfan-Dabaja, M. A.; Ganguly, S.; Maziarz, R. T.; Kanakry, C. G.; Kanakry, J. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients
    Research Letter

    Tan, C. R.; Estrada-Merly, N.; Landau, H.; Lekakis, L.; Banerjee, R.; Mian, H.; Usmani, S. Z.; Hanbali, A.; Lazarus, H. M.; Kyle, R. A.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Human herpesvirus 6 DNAemia is associated with worse survival after ex vivo T-cell-depleted hematopoietic cell transplant
    Journal Article

    Lee, Y. J.; Su, Y.; Cho, C.; Tamari, R.; Perales, M. A.; Jakubowski, A. A.; Papanicolaou, G. A.
    Journal of Infectious Diseases (2022)

    Fulltext@MSK | Save
  • Donor-CD4(+) T cells: A trojan horse for human herpes virus-6 after allogeneic hematopoietic cell transplantation?
    Correspondence

    Lee, Y. J.; Su, Y.; Cho, C.; Papanicolaou, G. A.
    Journal of Infectious Diseases (2022)

    Fulltext@MSK | Save
  • Randomized phase III BMT CTN trial of calcineurin inhibitor-free chronic graft-versus-host disease interventions in myeloablative hematopoietic cell transplantation for hematologic malignancies
    Journal Article

    Luznik, L.; Pasquini, M. C.; Logan, B.; Soiffer, R. J.; Wu, J.; Devine, S. M.; Geller, N.; Giralt, S.; Heslop, H. E.; Horowitz, M. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Impact of TP53 genomic alterations in large B-cell lymphoma treated with CD19-chimeric antigen receptor T-cell therapy
    Journal Article

    Shouval, R.; Alarcon Tomas, A.; Fein, J. A.; Flynn, J. R.; Markovits, E.; Mayer, S.; Afuye, A. O.; Alperovich, A.; Anagnostou, T.; Besser, M. J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
    Journal Article

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Ruiz, J. D.; Klein, E.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save